Harvard Heart Letter

New drug fizzles at raising HDL

With the failure of torcetrapib, a drug that its maker hoped would raise HDL cholesterol, people seeking to lower their heart disease risk should rely on traditional strategies: exercise, diet, weight control.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »